The mission of the Johns Hopkins Translational Tissue Engineering Center is to blaze new trails in the fields of tissue engineering and immunoengineering while training tomorrow’s top researchers and accelerating the delivery of regenerative medicine technologies to patients.
The Johns Hopkins Institute for NanoBioTechnology at Johns Hopkins University is a diverse, multidisciplinary team of faculty, researchers, and student experts uncovering new knowledge and creating innovative technologies at the interface of nanoscience, engineering, biology, and medicine.
Founded in 2016 with a series of philanthropic investments totaling $125 million, the Bloomberg~Kimmel Institute for Cancer Immunotherapy is a groundbreaking collaboration between clinical and scientific specialties, supporting cancer immunotherapy research across many cancer types.
The mission of the Institute for Cell Engineering is to foster a multidisciplinary environment in which experts from across the Johns Hopkins University collaborate to understand the biology of stem cells, basic cell processes, and how to apply new ideas to further the field of cell engineering.
The mission of the Johns Hopkins Department of Pathology is to discover, disseminate and apply knowledge in the study of diseases, to advance the field of human healthcare, and to provide the highest quality of patient care.
The Johns Hopkins Department of Biomedical Engineering’s position within the Whiting School of Engineering and the School of Medicine allows close collaborations with leading physicians and industry partners, providing a strong foundation for translating advances to first clinical use.